NASDAQ:HOOK
Hookipa Pharma Inc. Stock News
$0.768
-0.0320 (-4.00%)
At Close: May 10, 2024
Could Gilead Sciences Have an HIV Cure Waiting in the Wings? | The Motley Fool
11:03am, Sunday, 14'th Jun 2020
Treating COVID-19 is great. But the real game-changer for Gilead could be in curing HIV.
Hedge Funds Are Selling HOOKIPA Pharma Inc. (HOOK)
06:04pm, Friday, 12'th Jun 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
Why HOOKIPA (HOOK) Stock Might be a Great Pick
12:34pm, Thursday, 11'th Jun 2020
HOOKIPA (HOOK) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
HOOKIPA Pharma to Present at Jefferies Virtual Healthcare Conference
11:30am, Tuesday, 26'th May 2020
NEW YORK and VIENNA, Austria, May 26, 2020 -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious.
HOOKIPA Pharma Inc. (NASDAQ:HOOK) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
01:31pm, Sunday, 17'th May 2020
As you might know, HOOKIPA Pharma Inc. (NASDAQ:HOOK) recently reported its first-quarter numbers. It wasn't the...
HOOKIPA Pharma Inc (HOOK) Reports Q1 Loss, Misses Revenue Estimates
12:15pm, Thursday, 14'th May 2020
HOOKIPA Pharma Inc (HOOK) delivered earnings and revenue surprises of -10.26% and -15.13%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
HOOKIPA Pharma Reports First Quarter 2020 Financial Results and Provides a Corporate Update
11:00am, Thursday, 14'th May 2020
HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today
Will HOOKIPA Pharma Inc (HOOK) Report Negative Earnings Next Week? What You Should Know
04:30pm, Thursday, 07'th May 2020
HOOKIPA Pharma Inc (HOOK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HOOKIPA Pharma To Report First Quarter 2020 Financial Results on May 14, 2020
11:00am, Monday, 04'th May 2020
HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today
Hookipa Pharma Inc (NASDAQ:HOOK) Shares Purchased by Bank of New York Mellon Corp
09:04am, Thursday, 30'th Apr 2020
Bank of New York Mellon Corp increased its position in shares of Hookipa Pharma Inc (NASDAQ:HOOK) by 113.4% during the fourth quarter, according to the company in its most recent Form 13F filing with
HOOKIPA Pharma to Present at Upcoming Conferences in May
11:00am, Wednesday, 29'th Apr 2020
NEW YORK and VIENNA, Austria, April 29, 2020 -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious.
HOOKIPA Pharma Announces Publication of HB-101 Phase 1 Results in The Journal of Infectious Diseases
11:00am, Tuesday, 21'st Apr 2020
HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today
Did Changing Sentiment Drive HOOKIPA Pharma's (NASDAQ:HOOK) Share Price Down By 43%?
02:33pm, Sunday, 19'th Apr 2020
Passive investing in an index fund is a good way to ensure your own returns roughly match the overall market. When you...
Hookipa Pharma Inc (NASDAQ:HOOK) Short Interest Up 38.6% in March
05:44am, Thursday, 16'th Apr 2020
Hookipa Pharma Inc (NASDAQ:HOOK) was the target of a large increase in short interest in March. As of March 31st, there was short interest totalling 166,000 shares, an increase of 38.6% from the March
Howland Capital Management LLC Invests $122,000 in Hookipa Pharma Inc (NASDAQ:HOOK)
10:34am, Tuesday, 14'th Apr 2020
Howland Capital Management LLC acquired a new stake in shares of Hookipa Pharma Inc (NASDAQ:HOOK) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange
